Can Serum Lactate Dehydrogenase Level be Used for Predicted to IPF Clinical Severity?
Can Serum Lactate Dehydrogenase Level be Used for Predicted to IPF Clinical Severity?
About this item
Full title
Author / Creator
Publisher
Ankara: Aves Yayincilik Ltd. STI
Journal title
Language
Formats
Publication information
Publisher
Ankara: Aves Yayincilik Ltd. STI
Subjects
More information
Scope and Contents
Contents
Objectives: Serum lactate dehydrogenase (LDH) is a marker of cell damage and may be reflect pulmonary fibrosis. In a recent studies represented LDH level may related to pathogenesis and prognosis of idiopathic pulmonary fibrosis (IPF). We aimed to investigated relationship between serum LDH level and IPF severity. Methods: We retrospectively evalua...
Alternative Titles
Full title
Can Serum Lactate Dehydrogenase Level be Used for Predicted to IPF Clinical Severity?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2548682563
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2548682563
Other Identifiers
ISSN
2149-2530
E-ISSN
2149-2530,2979-9139
DOI
10.5152/TurkThoracJ.2019.158
